Immunotherapy using your own cells for advanced melanoma
Part of Cancer, Skin clinical trials.
This study tests an experimental treatment made from your own immune cells. The cells are collected, trained in the lab to recognize your melanoma, and then injected near your lymph nodes to help your immune system fight the cancer. This is for people whose melanoma has not responded to standard immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have melanoma that cannot be removed by surgery or has spread to other parts of the body.
- Your melanoma has not responded to at least one previous immunotherapy treatment, such as pembrolizumab or nivolumab.
- You are willing to stop taking immunotherapy (PD-1 inhibitors) for at least six weeks after the first study treatment.
- You have at least one tumor that can be safely biopsied or removed to create the study treatment.
- You must have adequate organ function (kidney, liver, bone marrow) and be generally fit (ECOG 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
This trial tests a treatment that uses your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight melanoma. Some participants also get a drug called pembrolizumab. The goal is to see if this approach can shrink tumors.
This trial tests a treatment using your own immune cells to fight advanced melanoma. The cells are taken from a tumor, grown in a lab, and given back to you either near the tumor or throughout your body.
This trial tests a new T-cell therapy made from your own tumor (TILs), genetically edited to remove the PD1 checkpoint blocker. It may help your immune system fight melanoma that has not responded to standard treatments like anti-PD1 therapy.
This trial tests a new treatment called ADP-TILIL7 for people with advanced melanoma. It uses your own immune cells (T-cells) that are taken from a tumor, multiplied in a lab, and then given back to you to fight the cancer. The goal is to see if this treatment is safe and works better than standard options.
Hear when a new Refractory Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.